A placebo-controlled, double-blind, phase II clinical trial (the ELAD trial) testing liraglutide in over 200 patients with mild cognitive impairments/AD for 1 year showed that neuronal loss was reduced by the drug (Colin et al
In the event of glutamate deprivation or GLS1 inhibition, there is a concomitant reduction in cell viability and elevation in G1 phase
Participants lost 16.7% of baseline weight over 64 weeks, matching clinical trial outcomes despite using half the typical drug dose
For individuals who focus on wellness and self-care, vitamin injections have become a valuable tool for enhancing vitality and overall well-being
Demand for GLP-1 alternatives has fueled an explosion of OTC products
However, the most significant changes taking place in a womans body during this transition are that theres increasing loss of ovarian follicles (called follicular atresia) and therefore a decreasing amount of estrogen being produced